Chargement en cours...
Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression
Clonal heterogeneity has not been described in patients with myelodysplastic syndrome with isolated del(5q), for which lenalidomide has emerged as a highly potent treatment. However, transformation to acute myeloid leukemia is occasionally observed, particularly in patients without a cytogenetic res...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Ferrata Storti Foundation
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2791931/ https://ncbi.nlm.nih.gov/pubmed/19797731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.011528 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|